Satellos Bioscience, Inc.
Nasdaq MSLE · Markham, Ontario, Canada
Works in Genetic & rare · Musculoskeletal · Neurology
Satellos Bioscience, Inc. is a clinical trial sponsor based in Markham, Ontario, Canada, listed as Nasdaq MSLE. It has 3 active clinical trials with 132 planned participants, in Genetic & rare, Musculoskeletal and Neurology. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq MSLE
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Satellos Bioscience, Inc
Satellos Bioscience, Inc is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 132 planned participants, in Genetic & rare, Musculoskeletal, Neurology. Since 2021 it has completed 1 trial and stopped 0 early.
Satellos Bioscience, Inc is based in Markham, Ontario, Canada and is listed as Nasdaq MSLE. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Satellos Bioscience, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
Approve Suite is not affiliated with Satellos Bioscience, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.